Dietary management of celiac disease: revisiting the guidelines by Theodoridis, Xenophon et al.
Dietary management of celiac disease: revisiting the 
guidelines
THEODORIDIS, Xenophon, GRAMMATIKOPOULOU, Maria G, PETALIDOU, 
Arianna, PATELIDA, Maria, GKIOURAS, Konstantinos, KLONIZAKIS, Markos 
<http://orcid.org/0000-0002-8864-4403>, PITTAS, Stefanos and BOGDANOS, 
Dimitrios P
Available from Sheffield Hallam University Research Archive (SHURA) at:
http://shura.shu.ac.uk/24478/
This document is the author deposited version.  You are advised to consult the 
publisher's version if you wish to cite from it.
Published version
THEODORIDIS, Xenophon, GRAMMATIKOPOULOU, Maria G, PETALIDOU, 
Arianna, PATELIDA, Maria, GKIOURAS, Konstantinos, KLONIZAKIS, Markos, 
PITTAS, Stefanos and BOGDANOS, Dimitrios P (2019). Dietary management of 
celiac disease: revisiting the guidelines. Nutrition. 
Copyright and re-use policy
See http://shura.shu.ac.uk/information.html
Sheffield Hallam University Research Archive
http://shura.shu.ac.uk
 1 
Abstract 
Objective: Medical nutrition therapy (MNT), by lifelong compliance to a gluten free diet, is the 
only treatment of celiac disease (CD). Clinical practice guidelines (CPGs) regarding the 
management of CD emphasize on the role of MNT besides other treatment options. The aim of 
the present study was to review and critically appraise CD-specific MNT CPGs, and identify the 
areas in need of improvement for better adherence and outcomes. 
Research Methods & Procedures: A comprehensive search was performed at Pubmed, Guidelines 
International Network (GIN), Google Scholar and related websites for CPGs on the dietary 
management of CD, published in the English language. 
Results: A total of 12 CPGs were retrieved and critically appraised by three independent reviewers 
utilizing the AGREE II instrument. All CPGs were of low quality based on AGREE II tool. Among the 
12 CPGs, the NICE ones achieved the highest score and was unanimously recommended without 
modifications by the three reviews, while AGA, AHS, BSPGHAN, CREST and FISPGHAN CPGs 
received the lowest score. 
Conclusions: The present study unveils the low quality of guidelines regarding the MNT of CD 
patients, indicating the need of updated and improved guidelines taking into consideration the 
proposed items of the AGREE II. 
Keywords: medical nutrition therapy; clinical practice; critical appraisal; gluten-free diet; 
autoimmune disease; nutrition intervention; evidence-based nutrition; gluten; CASP. 
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1. INTRODUCTION  
Celiac disease (CD) is an autoimmune enteropathy, triggered by the consumption of gluten 
proteins in genetically prone individuals of all ages [1,2]. Since nutrition is the most important 
effector of autoimmunity in susceptible patients [3], medical nutrition therapy (MNT) 
characterized by life-long adherence to a gluten free diet (GFD), consists of the only effective 
treatment of CD [4]. An early initiation and strict adherence to GFD does not only reverse villus 
atrophy triggered by exposure to gluten, but may also avert CD-related comorbidities including 
osteoporosis, malignancies and infertility [5], while simultaneously improve patients’ quality of life 
[6]. 
 
Even though a gluten restrictive diet is the only accepted efficient therapy for CD [4,7] adherence, 
rates to the GFD range from 59 to 95% [8] irrespectively of the seriousness of the concurrent 
comorbidities [9]. This highly heterogeneous adherence range may be the end result of poor 
compliance by affected patients in addition to ineffective handling and improper management of 
CD, as applied by experts and non-experts gastroenterologists [10]. Lack of proper patients follow-
up has been identified as an important barrier to dietary adherence [9]. Additionally, obstacles to 
conformity to a GFD include the availability and adulteration of gluten free products [8], their 
higher cost compared to regular consumer goods [11,12], and the ambiguous labelling of food 
products [13]. 
 
Apart from immunotherapy, clinical practice guidelines (CPGs) for the management of CD 
emphasize on the role of MNT. However, according to a systematic review [7] among the various 
therapeutic components of CD, MNT appears to have the lowest compliance rates. Persistent data 
reveal that follow-up of CD patients is often inadequate [14], missing important critical compliance 
points [15], while in parallel, gastroenterologists are applying diverse practices, with many not 
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assessing the level of adherence to a GFD and some not reinforcing patients on the importance of 
GFD compliance [16]. These findings highlight the need for robust, high-quality CPGs for CD 
management, aiming to provide clinicians with a step-by-step procedure based on evidence-based 
criteria, improve clinician adherence, standardize and improve patient care [17]. 
 
Several CPGs have been issued over the years by various associations, mainly Gastroenterology 
Societies (adult and pediatric), but also Nutrition and Dietetic Associations, most from Europe and 
North America. The aim of the study was to review and critically appraise CPGs regarding the CD-
specific MNT, identify shortcomings and provide information concerning the areas needing 
improvement during CPGs development. 
 
2. MATERIAL AND METHODS 
2.1 Search strategy 
A search was performed in Pubmed, Guidelines International Network (GIN), Guidelines CENTRAL, 
Google Scholar, and websites of related societies. The search terms used were (guidelines), 
(medical nutrition therapy), (gluten free diet), (management), (care), (clinical practice), 
(consensus), and (celiac disease). 
 
Inclusion criteria involved CPGs published in the English language, containing CD-MNT 
information. Any other forms of publication such as books, and articles written in languages other 
than English, were excluded. When previous versions of updated CPGs were retrieved, they were 
excluded from the appraisal process and the most recent one was used. 
 
2.2 Critical appraisal of the retrieved CPGs 
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The included CPGs were evaluated by three independent reviewers utilizing the Appraisal of 
Guidelines Research & Evaluation (AGREE) II instrument [18]. The AGREE II tool assesses the 
rigour, bias and quality of CPGs via 23 distinct items within six main domains [18]. The AGREE is 
applicable to CPGs of all specialties, including nutrition [19]. The total score of each CPG is 
calculated as a percentage of the maximum possible score (based on the number of reviewers), 
while all reviewers additionally state their opinion on whether they recommend, or reject 
adherence to specific CPGs [18]. 
 
2.3 Pooling CD-MNT recommendations 
MNT recommendations from each CPG were extracted by two reviewers independently in an 
excel file. When information was ambiguous, disagreement was resolved by a third reviewer 
following constructive discussion. Overview tables were constructed with all nutrition-related 
recommendations available in the CPGs. 
 
3. RESULTS 
A total of 12 CPGs published by the American College of Gastroenterology (ACG) [20], the 
American Gastroenterology Association (AGA) [21], Alberta Health Services (AHS) [22], the British 
Society of Gastroenterology (BSG) [23]. the British Society of Paediatric Gastroenterology, 
Hepatology and Nutrition (BSPGHAN) [24], the American Academy of Nutrition and Dietetics 
(Academy) [25], the Clinical Resource Efficiency Support Team (CREST) [26], the Federation of 
International Societies of Pediatric Gastroenterology, Hepatology and Nutrition (FISPGHAN) [27], 
the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition (NASPGHAN) 
[28], the National Institute for Health and Care Excellence (NICE) [29], the World Gastroenterology 
Organization (WGO) [30], and the American Academy of Pediatrics expert panel (AAP-EP) [31] 
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were retrieved (Table 1). Four were specific on pediatric patients, two were destined for adult 
patients and the remaining were for either age group. 
 
Table 2 details the AGREE scores of each CPG. Overall, the quality of guidelines was low, with all 
CPGs achieving a score lower than 65%. Scores in the scope and purpose domain were high for 
most CPGs, exceeding 66.7%. The greatest score in this domain was received by the Academy [25] 
and NICE [29] reaching 98.1%. In the stakeholder involvement domain the Academy [25] received 
the greatest score, whereas the lowest score (31.5%) was received by the AGA [21] CPGs. Most 
CPGs failed to include a multidisciplinary team and patients in the CPGs development, scoring low 
in this specific domain. In the rigor of development domain the FISPGHAN [27] scored the lowest 
(14.6%), for failing to report search methods and formulations recommendations and for 
underreporting evidence selection criteria, strengths and limitations and for not explicitly 
considering benefits and harms. The rigor domain was mostly met by the NICE [29] (72.2%) CPGs. 
The Academy [25] CPGs demonstrated the highest presentation clarity (85.2%) and applicability 
(68.1%). Greater editorial independence was demonstrated by the ACG [20], BSG [23], and AAP-EP 
[31] reaching 100%. Half of the appraised CPGs [21,22,26,28–30] received the lowest possible 
score in the editorial independence domain (0%), for failing to disclose funding and competing 
interests of members. Among appraised CPGs, the NICE guidelines [29] obtained the highest score 
and were unanimously recommended by the review panel, while the AGA [21], AHS [22], 
BSPGHAN [24], CREST [26] and FISPGHAN [27] CPGs received the lowest scores. 
 
Table 3 details the grading system used in each CPG for recommendations formulation. Different 
grading systems were utilized by the advising bodies, with the ACG [20] and AAP-EP [31] CPGs 
using the Grading of Recommendations, Assessment, Development and Evaluations (GRADE) 
 6 
system [32], and the BSG [23] and NASPGHAN [28] guidelines implementing the Oxford Centre for 
Evidence-based Medicine [33] and the Canadian Preventive Services Task Force [34], respectively. 
 
An overview of the recommendations regarding CD-specific MNT are outlined in Tables 4 and 5. 
All CPGs underlined the need for involving a dietitian in the therapy, however, detailed nutritional 
recommendations and important issues on nutritional management were lacking from the 
majority of CPGs. 
 
4. DISCUSSION 
The present approach reveals that current CPGs regarding the MNT of CD patients, are, in their 
majority, of low quality, scoring inadequately in several AGREE domains, indicating bias, lack of 
objectivity and of an evidence-based approach during CPGs development. Identification of the 
domains needing further improvement is important for ameliorating physician and patient 
adherence, and improving health-related outcomes. 
 
Over the last three decades CPGs development has evolved from an expert consensus matter, to 
an evidence-based medicine approach. However, despite the evolution observed in CPGs 
development, quality of most CPGs remains suboptimal [19,35]. Defined scope and purpose are 
important items of CPGs development, detailed in by all appraised CPGs herein. As far as key 
stakeholder involvement is concerned, low scores were observed in all CPGs with the exception of 
the AND [25] and NICE [29] ones. It should be noted that target population preferences and views 
were not accounted for in either CPGs, reducing the overall domain score. Many organizations 
recommend the inclusion of patients, patient representatives, or health consumers in the CPGs 
development panel [36], but CPGs often inadvertently focus on physicians solely [37]. Patient 
involvement in particular, is an important factor in CPGs development, enhancing 
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implementability and patient adherence, while ameliorating disease outcome [36]. However, to 
date, very few guidelines are incorporating members of the public in their development [38]. With 
studies indicating extremely variable adherence to GFD [15] and the desire of patients and their 
families for improved treatment [39], the absence of patient involvement indicates lack of a 
realistic approach for CPGs implementation. 
 
Low rigor was observed in many guidelines pointing out the lack of search methods, formulation 
of recommendations, external review, and updating procedures. The use of grading systems for 
the formulation of recommendations is important to identify indirectness, risk of bias, 
inconsistency, imprecision, and the magnitude of effect of the studies supporting each 
recommendation [40], while supporting evidence-based medicine. On the other hand, thorough 
external review is an important part of the CPGs development process, determining the 
applicability, clarity and validity [41], and was only accounted for adequately by the BSG [23] and 
the BSPGHAN [24]. All CPGs appraised, failed to mention a scheduled update procedure, except 
for the Academy [25]. 
 
Most of the CPGs provided specific, unambiguous and identifiable key recommendations, but 
demonstrated low applicability. The Academy guidelines [25] yielded the highest score in the 
applicability domain, providing methods to translate evidence to simple practice points and 
comprehensible monitoring criteria, while taking into account the financial factors of 
implementing the guidelines. On the one hand, adhering to a GFD is usually costly for the patients 
[11], however, on the other hand, could curtail healthcare costs [42]. As far as editorial 
independence is concerned, half of the guidelines [21,22,26,28–30] neglected to mention their 
funding sources and the conflicts of interest (COI) of each author, reducing the trustworthiness of 
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their recommendations [43]. When COIs are not mentioned it is not possible to exclude authors 
from participating in specific recommendations when important COI is involved [37]. 
 
Many studies highlight the vital role of dietitians in CD management [44–47] and the cost-
effectiveness of dietitian visits in CD [48]. In fact, dietitians are the only competent health 
professionals for educating patients and their relatives on nutrition matters [45,49]. In parallel, CD 
patients have reported preferring having meetings with dietitians [46] over other health 
professionals, and tend to exhibit improved GFD adherence when regular dietetic follow-ups are 
scheduled [45]. Interestingly, despite the fact that diet is the only effective therapy for CD, less 
than ¼ of patients in Australia and New Zealand and approximately ¾ of New Yorker with CD have 
had an appointment with a dietitian specialized in their disease [50]. In fact, according to an 
Australian survey [51], 78% of category 2 and 3 patients referred to the gastroenterologist could 
be managed exclusively in a dietitian-led clinic. In discordance with the acknowledgement of all 
included CPGs that a dietitian should be a part of a multidisciplinary team in management of CD, 
five out of twelve of the guidelines [20,27,28,30,31] did not implicate a dietitian in the guideline 
development process, while 2/12 guidelines [22,29] failed to report whether a dietitian was 
deemed necessary in CD therapy. 
 
Allowed foods and foods to avoid were not reported by the majority of CPGs, despite research 
indicating that many CD patients are unable to correctly identify gluten‐free foods [50] and many 
overestimating their nutrition literacy [52]. Noteworthy, many of the appraised guidelines stressed 
the importance of the nutritional education of CD patients. According to research, poor knowledge 
may lead to dietary over‐restrictions, and poorer dietary adherence [12,50]. According to Swift 
and Woodward [53] nutrition education should be prescribed in CD patients in a manner akin to 
medication prescription in other disease. Inadequate patient education appears to be a universal 
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problem [53] and the recommendation for nutrition education suggested by some CPGs offers a 
promising note for better disease adherence and outcomes. 
 
The issue of oats consumption was stressed by most CPGs, suggesting the use of pure, 
uncontaminated oats in a moderate amount for most patients [20–26,30]. However, oats 
introduction must be performed with caution and close monitoring of the patient for adverse 
reactions [20]. Based on a recent systematic review and meta-analysis [54] there is no evidence 
indicating that addition of oats to a GFD affects symptoms, histology, immunity, or serologic 
features of patients. 
 
Standards for labelling of GF foods was missed by most CPGs, with the exception of the AGA [21] 
and BSPGHAN [24]. A preferred meal pattern was only suggested by the AHS [22]. As for the 
adoption of a lactose-free diet, the BSPGHAN [24] and NASPGHAN [28] did not recommend its use 
for the majority of children, except for those with more severe CD, or inadequate dietary 
compliance. 
 
Finally, oral nutrient supplements were deemed necessary by the NICE [29] and the Academy [25], 
in cases of inadequate micronutrient intake. The rest of the advising bodies failed to address the 
issue of micronutrient deficiencies in CD. In parallel, the need for nutritional assessment and 
routine screening was missed by most CPGs [22–24,27,29], despite the variety of nutritional 
deficiencies that often accompany CD [55,56]. 
 
As far as breastfeeding is concerned, the CREST [26] CPGs suggested that breastfeeding may delay 
the onset of CD, however, according to a more recent meta-analysis, infant feeding practices do 
not appear to have an effect on the risk of CD onset during childhood [57]. The remaining CPGs 
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were either more recent than the CREST, or did not include any information regarding 
breastfeeding. 
 
CPGs consist of one important foundation in the effort to improve healthcare [37]. CPGs 
adherence standardizes care and improves patient outcome [58], while, on the flip side, reasons 
for non-adherence behove us [17]. Limitations of the present study include the lack of appraisal of 
CPGs published in languages other than the English and in forms other than electronic. 
Furthermore, in our study three independent reviewers critical appraise the CPGs, while AGREE II 
tool recommends the employment of four reviewers for minimizing the risk of bias. The 
importance of the present review however, stems from the critical appraisal of the CPGs, 
providing information on the domains in need of improvement during future CPGs 
development/update in order to improve dietetic practice. Given that CD in particular is the 
opportunity for dietitians to showcase the efficacy of the nutrition science, a collective effort is 
needed to include dietitians in all nutrition-related CPGs and ameliorate the quality of the CPGs, in 
order to advance dietetic practice and provide evidence-based nutrition. 
 
5. CONCLUSION 
In conclusion, the aim of the present study was to critically appraise and review CPGs regarding 
CD-specific MNT, in an attempt to provide guidance for future enhancement of guidelines, leading 
to superior guidelines, improvement of healthcare services and simultaneously reducing 
healthcare costs. 
 
Funding: This research did not receive any specific grant from funding agencies in the public, 
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Table 1. General description of the retrieved guidelines and their scope. 
Advising Body 
Country/ 
Region 
Publication 
year 
Scope  Organization  Target Population 
Total 
pages 
CD management with 
enclosed MNT 
recommendations 
MNT 
for CD 
 
Professional Government 
 
Children Adults 
AAP-EP [31] N. America 2016 √   √   √  17 
Academy [25] USA 2015 √ √  √   √ √ 55 
ACG [20] USA 2013 √   √   √ √ 21 
AGA [21] USA 2005  √  √   √ √ 7 
AHS [22] Canada 2013 √   √   √ √ 6 
BSG [23] UK 2014 √   √    √ 22 
BSPGHAN [24] UK 2013 √   √   √  6 
CREST [26] Ireland 2006  √  √    √ 28 
FISPGHN [27] N. America 2008  √  √   √  6 
NASPGHAN 
[28] 
N. America 2005 √   √   √  19 
NICE [29] UK 2015 √    √  √ √ 145 
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Advising Body 
Country/ 
Region 
Publication 
year 
Scope  Organization  Target Population 
Total 
pages 
CD management with 
enclosed MNT 
recommendations 
MNT 
for CD 
 
Professional Government 
 
Children Adults 
WGO [30] International 2016 √   √   √ √ 35 
AAP-EP: American Academy of Pediatrics Expert Panel; Academy: Academy of Nutrition and Dietetics; ACG: American College of Gastroenterology; AGA: American 
Gastroenterology Association; AHS: Alberta Health Services; BSG: British Society of Gastroenterology; BSPGHAN: British Society of Pediatric Gastroenterology, 
Hepatology and Nutrition; CD: Celiac disease; CREST: Clinical Resource Efficiency Support Team; FISPGHAN: Federation of the Societies of Pediatric 
Gastroenterology, Hepatology, and Nutrition; MNT: Medical Nutrition Therapy; NASPGHAN: North American Society for Pediatric Gastroenterology, Hepatology 
and Nutrition; NICE: National Institute for Health and Clinical Excellence; WGO: World Gastroenterology Organization. 
 
  
 20 
Table 2. AGREE II scores of guidelines for the nutritional management of celiac disease (% of maximum scoring for each domain and subcategory*). 
AGREE II domains 
CPGs on the nutritional management of CD 
AAP-EP 
[31] 
Academy 
[25] 
ACG 
[20] 
AGA 
[21] 
AHS 
[22] 
BSG 
[23] 
BSPGHAN 
[24] 
CREST 
[26] 
FISPGHAN 
[27] 
NASPGHAN 
[28] 
NICE 
[29] 
WGO [30] 
1. Scope & purpose 85.2 98.1 87.0 77.8 83.3 88.9 83.3 92.6 72.2 96.3 98.1 87.0 
1a. Objectives 88.9 100 88.9 77.8 72.2 83.3 88.9 100 66.7 100 94.4 83.3 
1b. Questions 77.8 94.4 83.3 77.8 94.4 83.3 77.8 77.8 72.2 94.4 100 94.4 
1c. Populations 88.9 100 88.9 77.8 83.3 100 83.3 100 77.8 94.4 100 83.3 
2. Stakeholder involvement 59.3 81.5 40.7 31.5 33.3 50.0 27.8 53.7 27.8 55.6 77.8 40.7 
2a. Group membership 94.4 55.6 100 94.4 0.0 83.3 83.3 66.7 83.3 72.2 94.4 44.4 
2b. Patient views 0.0 88.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.6 50.0 0.0 
2c. Target users 83.3 100 22.2 0.0 100 66.7 0.0 94.4 0.0 88.9 88.9 77.8 
3. Rigor 59.0 36.1 28.0 18.1 16.0 69.4 14.6 15.3 14.6 56.9 72.2 22.9 
3a. Search methods 100 0.0 16.7 0.0 0.0 83.3 5.6 0.0 0.0 100 94.4 0.0 
3b. Evidence selection criteria 88.9 0.0 5.6 11.1 5.6 94.4 0.0 11.1 11.1 100 100 16.7 
3c. Evidence strengths & 
limitations 
72.2 50.0 55.6 16.7 5.6 77.8 0.0 0.0 11.1 55.6 83.3 11.1 
3d. Formulation of 83.3 0.0 0.0 0.0 0.0 94.4 0.0 11.1 0.0 72.2 94.4 11.1 
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AGREE II domains 
CPGs on the nutritional management of CD 
AAP-EP 
[31] 
Academy 
[25] 
ACG 
[20] 
AGA 
[21] 
AHS 
[22] 
BSG 
[23] 
BSPGHAN 
[24] 
CREST 
[26] 
FISPGHAN 
[27] 
NASPGHAN 
[28] 
NICE 
[29] 
WGO [30] 
recommendations 
3e. Benefits & harms 
consideration 
16.7 77.8 61.1 66.7 55.6 16.7 0.0 50.0 38.9 38.9 94.4 44.4 
3f. Recommendations & 
evidence link 
88.9 61.1 83.3 50.0 61.1 88.9 11.1 50.0 55.6 77.8 100 88.9 
3g. External review 11.1 0.0 0.0 0.0 0.0 94.4 100 0.0 0.0 11.1 11.1 11.1 
3h. Updating procedures 11.1 100 0.0 0.0 0.0 5.6 0.0 0.0 0.0 0.0 0.0 0.0 
4. Clarity of presentation 75.9 85.2 63.0 57.4 74.1 64.8 48.1 81.5 66.7 53.7 74.1 77.8 
4a. Specific, unambiguous 
recommendations 
83.3 88.9 88.9 66.7 83.3 94.4 72.2 94.4 66.7 94.4 94.4 94.4 
4b. Management options 55.6 83.3 11.1 38.9 44.4 0.0 0.0 55.6 44.4 11.1 27.8 44.4 
4c. Identifiable key 
recommendations 
88.9 83.3 88.9 66.7 94.4 100 72.2 94.4 88.9 55.6 100 94.4 
5. Applicability 44.4 68.1 26.4 37.5 45.8 40.3 36.1 61.1 34.7 43.1 55.6 37.5 
5a. Facilitators & barriers to 44.4 50.0 27.8 61.1 27.8 38.9 33.3 66.7 50.0 38.9 27.8 38.9 
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AGREE II domains 
CPGs on the nutritional management of CD 
AAP-EP 
[31] 
Academy 
[25] 
ACG 
[20] 
AGA 
[21] 
AHS 
[22] 
BSG 
[23] 
BSPGHAN 
[24] 
CREST 
[26] 
FISPGHAN 
[27] 
NASPGHAN 
[28] 
NICE 
[29] 
WGO [30] 
application 
5b. Implementation 
advice/tools 
5.6 83.3 11.1 72.2 66.7 0.0 44.4 94.4 11.1 16.7 33.3 16.7 
5c. Resource implications 66.7 77.8 0.0 0.0 61.1 55.6 0.0 16.7 44.4 44.4 77.8 11.1 
5d. Monitor/audit criteria 61.1 61.1 66.7 16.7 27.8 66.7 66.7 66.7 33.3 72.2 83.3 83.3 
6. Editorial Independence 100 75.0 100 0.0 0.0 100 50.0 0.0 50.0 0.0 0.0 0.0 
6a. Funding body 100 50.0 100 0.0 0.0 100 0.0 0.0 0.0 0.0 0.0 0.0 
6b. Competing interests 100 100 100 0.0 0.0 100 100 0.0 100 0.0 0.0 0.0 
Overall quality 61.1 55.6 55.6 38.9 38.9 61.1 38.9 38.9 38.9 50.0 66.7 50.0 
Recommendation:             
Without Modification 33.3 100 66.6 0 33.3 100 0 33.3 0 33.3 100 66.6 
With Modification 66.6 0 33.3 66.6 66.6 0 100 66.6 33.3 66.6 0 33.3 
Not recommended 0 0 0 33.3 0 0 0 0 66.6 0 0 0 
AAP-EP: American Academy of Pediatrics Expert Panel; Academy: Academy of Nutrition and Dietetics; ACG: American College of Gastroenterology; AGA: American 
Gastroenterology Association; AGREE: Appraisal of Guidelines Research & Evaluation; AHS: Alberta Health Services; BSG: British Society of Gastroenterology; BSPGHAN: British 
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AGREE II domains 
CPGs on the nutritional management of CD 
AAP-EP 
[31] 
Academy 
[25] 
ACG 
[20] 
AGA 
[21] 
AHS 
[22] 
BSG 
[23] 
BSPGHAN 
[24] 
CREST 
[26] 
FISPGHAN 
[27] 
NASPGHAN 
[28] 
NICE 
[29] 
WGO [30] 
Society of Pediatric Gastroenterology, Hepatology and Nutrition; CD: Celiac Disease; CPGs: Clinical Practice Guidelines; CREST: Clinical Resource Efficiency Support Team; 
FISPGHAN: Federation of the Societies of Pediatric Gastroenterology, Hepatology, and Nutrition; NASPGHAN: North American Society for Pediatric Gastroenterology, 
Hepatology and Nutrition; NICE: National Institute for Health and Clinical Excellence; WGO: World Gastroenterology Organization. 
* Highest score in each principal domain is presented in bold. 
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Table 3. Grading system used for recommendation formulation in the retrieved guidelines. 
Grading systems Codes of evidence and recommendation 
CPGs  Level of evidence Strength of 
recommendation 
GRADE [32] A, B, C 1, 2 ACG [20], AAP-EP [31] 
mGRADE A, B, C 1, 2 NICE [29] 
Oxford Centre for Evidence-
based Medicine [33] 
1a, 1b, 1c, 2a, 2b, 
2c, 3a, 3b, 4, 5 
A, B, C, D 
BSG [23] 
Canadian Task force on 
Preventive Health Care [59] 
  
NASPGHAN [28] 
Academy Recommendation 
Rating Scheme [60] 
  
Academy [25] 
None Reported   AGA [21], AHS [22], BSPGHAN 
[24], CREST [26], FISPGHAN [27], 
WGO [30] 
Academy: Academy of Nutrition and Dietetics; ACG: American College of Gastroenterology; AGA: American 
Gastroenterology Association; AHS: Alberta Health Services; BSG: British Society of Gastroenterology; 
BSPGHAN: British Society of Pediatric Gastroenterology, Hepatology and Nutrition; CPGs: Clinical Practice 
Guidelines; CREST: Clinical Resource Efficiency Support Team; GRADE: Grading of Recommendations 
Assessment, Development and Evaluation; mGRADE: Modified Grading of Recommendations Assessment, 
Development and Evaluation; NASPGHAN: North American Society for Pediatric Gastroenterology, 
Hepatology and Nutrition; NICE: National Institute for Health and Clinical Excellence; WGO: World 
Gastroenterology Organization. 
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Table 4. Outline of the general nutrition recommendations included in the clinical practice guidelines for Celiac Disease Medical Nutrition Therapy. 
Recommendations: 
CPGs by advising bodies: 
AAP-EP 
[31] 
Academy 
[25] 
ACG 
[20] 
AGA 
[21] 
AHS 
[22] 
BSG [23] BSPGHAN 
[24] 
CREST 
[26] 
FISPGHAN 
[27] 
NASPGHAN 
[28] 
NICE 
[29] 
WGO 
[30] 
Dietitian Needed: √ √ √ √ √ √ √ √ √ √ √ √ 
Nutrition Education: √ √ √ √        √ 
Nutritional Assessment: √ √ √ √    √  √  √ 
Routine Screening: √ √ √ √    √  √  √ 
Allowed Foods:  √  √    √    √ 
Foods to Avoid:   √ √ √   √    √ 
Gluten intake limit:      < 10 
mg/d 
     10–100 
mg/d 
Academy: Academy of Nutrition and Dietetics; ACG: American College of Gastroenterology; AGA: American Gastroenterology Association; AHS: Alberta Health Services; BSG: 
British Society of Gastroenterology; BSPGHAN: British Society of Pediatric Gastroenterology, Hepatology and Nutrition; CPGs: Clinical Practice Guidelines; CREST: Clinical Resource 
Efficiency Support Team; NASPGHAN: North American Society for Pediatric Gastroenterology, Hepatology and Nutrition; NICE: National Institute for Health and Clinical 
Excellence; WGO: World Gastroenterology Organization. 
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Table 5. Issues of nutritional concern included in the clinical practice guidelines for celiac disease medical nutrition therapy. 
Recommendations: 
CPGs by advising bodies: 
Academy 
[25] 
ACG [20] AGA [21] AHS [22] BSPGHAN [24] CREST [26] NASPGHAN 
[28] 
NICE [29] WGO [30] 
Oats: Ιncorporating 
pure oats (50 
g dry oats/d) 
with wheat, 
barley or rye 
is safe and 
improves GFD 
compliance. 
Pure oats a-
re safely to-
lerated by 
most. Intro-
duced with 
caution and 
patient mo-
nitoring for 
adverse re-
actions. 
The inclusion 
of oats and 
wheat starch 
in the GFD is 
controversial. 
Consume mo-
derate amount 
of pure uncon-
taminated dry 
oats as follows: 
• adults ½ – ¾  
cup dry oats/d 
(125–175 mL) 
• children ¼ cup 
dry oats/d (60 
mL). 
Safe for most CD 
patients although 
5% of patients 
are oat-sensitive. 
Use uncontami-
nated oats only. 
Coeliac UK advise 
on a moderate in-
take (<50 g, i.e. 1 
serving) of pure 
oats/d by most 
celiacs, without 
risk. 
  Pure, unconta-
minated oats 
are not toxic for 
>95% of CD 
patients. 
Gluten-free 
products 
standards: 
  GF foods 
must have 
<20 ppm of 
gluten (20 mg 
 Products with 
barley malt ex-
tract must be <20 
ppm to be GF. 
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Recommendations: 
CPGs by advising bodies: 
Academy 
[25] 
ACG [20] AGA [21] AHS [22] BSPGHAN [24] CREST [26] NASPGHAN 
[28] 
NICE [29] WGO [30] 
gluten/1 kg). 
Other count-
ries use 200 
ppm. 
Codex wheat 
starch is used in 
GF or VLG foods.  
GF: safe for all 
unless separate 
non-coeliac whe-
at sensitivity. 
VLG: acceptable 
for most celiacs, 
except those 
with  gluten 
sensitivity. 
Meals:    3 regular meals 
and snacks daily 
     
Lactose-free diet 
(LFD): 
    Rarely needed, al-
though in some, 
 Most children 
with newly di-
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Recommendations: 
CPGs by advising bodies: 
Academy 
[25] 
ACG [20] AGA [21] AHS [22] BSPGHAN [24] CREST [26] NASPGHAN 
[28] 
NICE [29] WGO [30] 
temporary lacto-
se intolerance can 
coexist. More 
persistent lactose 
intolerance needs 
further assess-
ment to exclude 
inadequate diet-
ary compliance or 
additional patho-
logy requiring se-
parate treatment 
(eg, cow’s milk 
sensitive enter-
opathy). 
agnosed CD to-
lerate lactose, 
in moderate 
amounts. Thus, 
LFD is not ne-
cessary. Young 
children with 
more severe 
disease may 
benefit from a 
LFD initially. 
Oral Nutrient Consume a       Explain to pa-  
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Recommendations: 
CPGs by advising bodies: 
Academy 
[25] 
ACG [20] AGA [21] AHS [22] BSPGHAN [24] CREST [26] NASPGHAN 
[28] 
NICE [29] WGO [30] 
Supplements: gluten-free 
age- and sex-
specific MV 
and mineral 
ONS if usual 
food intake is 
inadequate 
and cannot 
be alleviated 
through imp-
roved eating. 
tients and fa-
milies that 
ONS (Ca, vit 
D) is needed 
in insufficient 
diets. 
Breastfeeding:      Recommended. It 
can delay CD 
onset. 
   
ACG: American College of Gastroenterology; AGA: American Gastroenterology Association; Academy: Academy of Nutrition and Dietetics; BSPGHAN: British Society of 
Pediatric Gastroenterology, Hepatology and Nutrition; CD: Celiac Disease; CPGs: Clinical Practice Guidelines; CREST: Clinical Resource Efficiency Support Team; GF: 
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Recommendations: 
CPGs by advising bodies: 
Academy 
[25] 
ACG [20] AGA [21] AHS [22] BSPGHAN [24] CREST [26] NASPGHAN 
[28] 
NICE [29] WGO [30] 
Gluten free (<20 ppm); GFD: Gluten-free diet; LFD: Lactose-free diet; MV: Multivitamin; NASPGHAN: North American Society for Pediatric Gastroenterology, 
Hepatology and Nutrition; NICE: National Institute for Health and Clinical Excellence; ONS: Oral nutrient supplements; VLG: Very low gluten (21–100 ppm); WGO: 
World Gastroenterology Organization; : high. 
 
